Modularity-based credible prediction of disease genes and detection of disease subtypes on the phenotype-gene heterogeneous network
暂无分享,去创建一个
[1] Yongjin Li,et al. Discovering disease-genes by topological features in human protein-protein interaction network , 2006, Bioinform..
[2] Jason H. Moore,et al. Exploiting the proteome to improve the genome-wide genetic analysis of epistasis in common human diseases , 2008, Human Genetics.
[3] G. Upton. Fisher's Exact Test , 1992 .
[4] Q. Cui,et al. Identification of high-quality cancer prognostic markers and metastasis network modules , 2010, Nature communications.
[5] Susumu Goto,et al. The commonality of protein interaction networks determined in neurodegenerative disorders (NDDs) , 2007, Bioinform..
[6] P. Robinson,et al. Walking the interactome for prioritization of candidate disease genes. , 2008, American journal of human genetics.
[7] Maricel G. Kann,et al. Protein interactions and disease: computational approaches to uncover the etiology of diseases , 2007, Briefings Bioinform..
[8] R. Bernards,et al. Enabling personalized cancer medicine through analysis of gene-expression patterns , 2008, Nature.
[9] Michael Q. Zhang,et al. Network-based global inference of human disease genes , 2008, Molecular systems biology.
[10] E. Levy-Lahad,et al. Fanconi anemia and breast cancer susceptibility meet again , 2010, Nature Genetics.
[11] H. Lehrach,et al. A protein interaction network links GIT1, an enhancer of huntingtin aggregation, to Huntington's disease. , 2004, Molecular cell.
[12] A. Howell,et al. Origins of breast cancer subtypes and therapeutic implications , 2007, Nature Clinical Practice Oncology.
[13] Jane Fridlyand,et al. Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis. , 2003, Cancer research.
[14] C. Daub,et al. BMC Systems Biology , 2007 .
[15] H. Brunner,et al. From syndrome families to functional genomics , 2004, Nature Reviews Genetics.
[16] Ash A. Alizadeh,et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling , 2000, Nature.
[17] Christopher Lawrence,et al. DEGENERATION , 2020, Side Effects May Include Strangers.
[18] Xuegong Zhang,et al. Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. , 2007, IET systems biology.
[19] M. Iles,et al. Multi-Variant Pathway Association Analysis Reveals the Importance of Genetic Determinants of Estrogen Metabolism in Breast and Endometrial Cancer Susceptibility , 2010, PLoS genetics.
[20] H. Wilkinson,et al. Characterization of a Novel Small Molecule Subtype Specific Estrogen-Related Receptor α Antagonist in MCF-7 Breast Cancer Cells , 2009, PloS one.
[21] G. Vriend,et al. A text-mining analysis of the human phenome , 2006, European Journal of Human Genetics.
[22] A. Barabasi,et al. A Protein–Protein Interaction Network for Human Inherited Ataxias and Disorders of Purkinje Cell Degeneration , 2006, Cell.
[23] Chitta Baral,et al. Mining Gene-Disease Relationships from Biomedical Literature: Weighting Proteinprotein Interactions and Connectivity , 2006, Pacific Symposium on Biocomputing.
[24] Yuan Qi,et al. Modularity and Dynamics of Cellular Networks , 2006, PLoS Comput. Biol..
[25] Pall I. Olason,et al. A human phenome-interactome network of protein complexes implicated in genetic disorders , 2007, Nature Biotechnology.
[26] Shiwen Zhao,et al. Network-Based Relating Pharmacological and Genomic Spaces for Drug Target Identification , 2010, PloS one.
[27] S. Bortoluzzi,et al. Disease genes and intracellular protein networks. , 2003, Physiological genomics.
[28] B. Snel,et al. Predicting disease genes using protein–protein interactions , 2006, Journal of Medical Genetics.
[29] R. Sharan,et al. Network-based prediction of protein function , 2007, Molecular systems biology.
[30] Jagdish Chandra Patra,et al. Genome-wide inferring gene-phenotype relationship by walking on the heterogeneous network , 2010, Bioinform..
[31] Edwin Wang. Cancer Systems Biology , 2010 .
[32] T. Jiang,et al. Modularity in the genetic disease‐phenotype network , 2008, FEBS letters.
[33] Xuebing Wu,et al. Cancer Gene Prediction Using a Network Approach , 2009 .
[34] Chen-Yang Shen,et al. Breast Cancer Risk Is Associated with the Genes Encoding the DNA Double-Strand Break Repair Mre11/Rad50/Nbs1 Complex , 2007, Cancer Epidemiology Biomarkers & Prevention.
[35] R. Cress,et al. Descriptive analysis of estrogen receptor (ER)‐negative, progesterone receptor (PR)‐negative, and HER2‐negative invasive breast cancer, the so‐called triple‐negative phenotype , 2007, Cancer.
[36] A. D’Andrea,et al. Susceptibility pathways in Fanconi's anemia and breast cancer. , 2010, The New England journal of medicine.
[37] Jason Y. Liu,et al. Analysis of protein sequence and interaction data for candidate disease gene prediction , 2006, Nucleic acids research.
[38] H. Wilkinson,et al. Estrogen-related receptor-α antagonist inhibits both estrogen receptor–positive and estrogen receptor–negative breast tumor growth in mouse xenografts , 2009, Molecular Cancer Therapeutics.
[39] Adrian V. Lee,et al. Estrogen receptor-positive, progesterone receptor-negative breast cancer: association with growth factor receptor expression and tamoxifen resistance. , 2005, Journal of the National Cancer Institute.
[40] Hanno Steen,et al. Development of human protein reference database as an initial platform for approaching systems biology in humans. , 2003, Genome research.
[41] M. Kibriya,et al. A CYP19 (aromatase) polymorphism is associated with increased premenopausal breast cancer risk , 2008, Breast Cancer Research and Treatment.
[42] M. Bani,et al. Single nucleotide polymorphisms of the aromatase gene (CYP19A1), HER2/neu status, and prognosis in breast cancer patients , 2008, Breast Cancer Research and Treatment.